Quantitative DNA methylation analysis: The promise of high-throughput epigenomic diagnostic testing in human neoplastic disease

Journal of Molecular Diagnostics

Volumn 8, Issue 2, 2006, Pages 152-156

  Coleman, William B ^a   Rivenbark, Ashley G ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT;

ARTICLE; CANCER DIAGNOSIS; COLORECTAL CANCER; COLORECTAL CARCINOMA; DIAGNOSTIC PROCEDURE; DNA METHYLATION; EPIGENETICS; ESOPHAGUS CANCER; GENE MUTATION; GLIOMA; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; PREDICTION; PROGNOSIS; PROSTATE CANCER; PROTEIN EXPRESSION; QUANTITATIVE DIAGNOSIS; REAL TIME POLYMERASE CHAIN REACTION;

EID: 33744527879     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2006.060026     Document Type: Note

References (28)

1. Waddington CH: The epigenotype. Endeavour 1942, 1:18-20
2. Hotchkiss RD: The quantitative separation of purines, pyrimidines, and nucleosides by paper chromatography. J Biol Chem 1948, 175:315-332
3. Bird A: The essentials of DNA methylation. Cell 1992, 70:5-8
4. Feinberg AP: The epigenetics of cancer etiology. Semin Cancer Biol 2004, 14:427-432
5. Murrell A, Rakyan VK, Beck S: From genome to epigenome. Hum Mol Genet 2005, 14:R3-R1O
6. Fuks F: DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev 2005, 15:490-495
7. Rodenhiser D, Mann M: Epigenetics and human disease: translating basic biology into clinical applications. Can Med Assoc J 2006, 174:341-348
8. Jiang YH, Bressler J, Beaudet AL: Epigenetics and human disease. Annu Rev Genomics Hum Genet 2004, 5:479-510
9. Novik KL, Nimmrich I, Genc B, Maier S, Piepenbrock C, Olek A, Beck S: Epigenomics: genome-wide study of methylation phenomena. Curr Issues Mol Biol 2002, 4:111-128
10. Ogino S, Kawasaki T, Brahmandam M, Cantor M, Kirkner GJ, Spiegelman D, Makrigiorgos GM, Weisenberger DJ, Laird PW, Loda M, Fuchs CS: Precision and performance characteristics of sodium bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn 2006, 8:209-217
11. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP: Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998, 72:141-196
12. Feinberg AP, Vogelstein B: Hypomethylation of ras oncogenes in primary human cancers. Biochem Biophys Res Commun 1983, 111:47-54
13. Feinberg AP, Vogelstein B: Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983, 301:89-92
14. Esteller M: Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br J Cancer 2006, 94:179-183
15. Feinberg AP, Tycko B: The history of cancer epigenetics. Nat Rev Cancer 2004, 4:143-153
16. Jones PA, Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002, 3:415-428
17. Herman JG, Baylin SB: Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003, 349:2042-2054
18. Bird A: DNA methylation patterns and epigenetic memory. Genes Dev 2002, 16:6-21
19. Yamashita R, Suzuki Y, Sugano S, Nakai K: Genome-wide analysis reveals strong correlation between CpG islands with nearby transcription start sites of genes and their tissue specificity. Gene 2005, 350:129-136
20. Bird AP: CpG-rich islands and the function of DNA methylation. Nature 1986, 321:209-213
21. Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomaki P, Lang JC, Schuller DE, Yu L, Bloomfield CD, Caligiuri MA, Yates A, Nishikawa R, Su Huang H, Petrelli NJ, Zhang X, O'Dorislo MS, Held WA, Cavenee WK, Plass C: Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 2000, 24:132-138
22. Ohtani-Fujita N, Fujita T, Aoike A, Osifchin NE, Robbins PD, Sakai T: CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Oncogene 1993, 8:1063-1067
23. Matsubara N: Diagnostic application of hMLH1 methylation in hereditary non-polyposis colorectal cancer. Dis Markers 2004, 20:277-282
24. Miyamoto K, Ushijima T: Diagnostic and therapeutic applications of epigenetics. Jpn J Clin Oncol 2005, 35:293-301
25. Laird PW: The power and the promise of DNA methylation markers. Nat Rev Cancer 2003, 3:253-266
26. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL: A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 1992, 89:1827-1831
27. Grunau C, Clark SJ, Rosenthal A: Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res 2001, 29:E65-E65
28. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW: MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000, 28:E32